Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis
- 24 January 2022
- journal article
- review article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 75 (2), 351-359
- https://doi.org/10.1007/s12020-021-02967-9
Abstract
Objective To analyze and explore the risk factors of skip lateral cervical lymph node metastasis (SLLNM) in papillary thyroid carcinoma (PTC). Methods PubMed, Web of Science, Embase, Cochrane, Wanfang, China National Knowledge Infrastructure, and China Science and Technology Journal databases, updated to April 4, 2021, were systematically searched for literature on the risk factors of SLLNM in PTC. The meta-analysis was completed using Stata 15.0 software after quality evaluation. The odds ratio (OR) and 95% confidence interval (CI) of each variable were calculated using fixed or random-effects models, and the publication bias was evaluated by the Egger’s test. Results A total of 28 studies with 10,682 cases were included in our meta-analysis; 1592 (14.90%) cases were positive for SLLNM. The meta-analysis showed that female sex (OR = 1.16, 95% CI = 1.02–1.31, P = 0.021), age ≥45 (OR = 1.60, 95% CI = 1.19–2.15, P = 0.002), tumor diameter ≤10 mm (OR = 2.23, 95% CI = 1.62–3.06, P < 0.001), and upper location of tumor (OR = 3.60, 95% CI = 2.65–4.89, P < 0.001) were risk factors for SLLNM in PTC patients. Hashimoto’s thyroiditis (OR = 1.02, 95% CI = 0.88–1.19, P = 0.777), multifocality (OR = 0.98, 95% CI = 0.75–1.28, P = 0.873), bilateral tumors (OR = 0.92, 95% CI = 0.70–1.19, P = 0.515), extrathyroidal extensions (OR = 1.07, 95% CI = 0.83–1.39, P = 0.598), and capsular invasion (OR = 0.93, 95% CI = 0.65–1.31, P = 0.660) were not closely related to SLLNM risk. Conclusion This study confirmed significant associations between SLLNM and female sex, age ≥45, tumor diameter ≤10 mm, and upper location of the tumor.This publication has 33 references indexed in Scilit:
- Patterns of Initial Recurrence in Completely Resected Papillary Thyroid CarcinomaThyroid®, 2017
- Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: Anatomic pathways of lymphatic spreadHead & Neck, 2017
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid CancerJournal of Clinical Oncology, 2015
- Papillary thyroid microcarcinomas located at the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasisSurgery, 2015
- Skip Lateral Neck Node Metastases in Papillary Thyroid CarcinomaWorld Journal of Surgery, 2012
- Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Skip Metastases in Thyroid Cancer Leaping the Central Lymph Node CompartmentArchives of Surgery, 2004
- Prognosis After Lymph Node Recurrence in Papillary Thyroid Carcinoma Depends on AgeThyroid®, 2001
- Papillary carcinoma of the thyroid I. Developing pattern of metastasisCancer, 1970